Association between clinical symptoms and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia

Table 2 Comparison of rs429358 allele and genotype frequencies between schizophrenia cases and controls

Models	Genotypic	Cases	Controls	χ²	OR (95%CI)	p vaule	p adjusted*
Allele
	C (n%)	77 (8.0)	69 (8.0)	0.218	0.92 (0.66–1.29)	0.64	0.71
	T (n%)	935 (92.0)	773 (92.0)	0.218	1.00	0.64	0.71
Codominant
	CC (n%)	4 (0.8)	2 (0.5)	0.922	1.64 (0.30–8.98)	0.63	0.12
	CT (n%)	69 (13.6)	65 (15.4)		0.87 (0.60–1.25)
	TT (n%)	433 (85.6)	354 (84.1)		1.00
Dominant
	TT (n%)	433 (85.6)	354 (84.1)	0.396	1.00	0.53	0.45
	CC + CT (n%)	73 (14.4)	67 (15.9)	0.396	0.89 (0.62–1.28)	0.53	0.45
Recessive
	TT + CT (n%)	502 (99.2)	419 (99.5)	0.348	1.00	0.55	0.08
	CC (n%)	4 (0.8)	2 (0.5)	0.348	1.67 (0.30–9.16)	0.55	0.08
Over-dominant
	TT + CC (n%)	437 (86.4)	356 (84.6)	0.603	1.00	0.44	0.25
	CT (n%)	69 (13.6)	65 (15.4)	0.603	0.87 (0.60–1.25)	0.44	0.25

ISSN: 1744-859X